CVS HEALTH Corp
Close on Oct 19, 2026
- Market cap
- $119.28B
- P/E (TTM)
- 24.6
- Dividend yield
- 2.87%
Earnings
Next report expected Oct 28, 2026, before market open (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Aug 5, 2026 | Before market open | $106.10B | $2.31 | $2.58 |
| Q1 FY2026 Ended Mar 31, 2026 | May 6, 2026 | Before market open | $100.40B | $2.30 | $2.57 |
| Q4 FY2025 Ended Dec 31, 2025 | Feb 10, 2026 | Before market open | $105.70B | $2.30 | $1.09 |
| Q3 FY2025 Ended Sep 30, 2025 | Oct 29, 2025 | Before market open | – | – | $1.60 |
| Q2 FY2025 Ended Jun 30, 2025 | Jul 31, 2025 | Before market open | $98.90B | $0.80 | $1.81 |
| Q1 FY2025 Ended Mar 31, 2025 | May 1, 2025 | Before market open | $94.60B | $1.41 | $2.25 |
| Q4 FY2024 Ended Dec 31, 2024 | Feb 12, 2025 | Before market open | $97.70B | $1.30 | $1.19 |
| Q3 FY2024 Ended Sep 30, 2024 | Nov 6, 2024 | Before market open | $95.40B | $0.07 | $1.09 |
| Q2 FY2024 Ended Jun 30, 2024 | Aug 7, 2024 | Before market open | – | – | – |
| Q1 FY2024 Ended Mar 31, 2024 | May 1, 2024 | Before market open | – | – | – |
| Q4 FY2023 Ended Dec 31, 2023 | Feb 7, 2024 | Before market open | – | – | – |
Company guidance
Outlook given with results on Aug 5, 2026, compared with the previous outlook
| Measure | Period | Guidance | vs. prior |
|---|---|---|---|
| Adjusted EPSnon-GAAP | full-year 2026 | $7.90 to $8.10 | Raised |
| GAAP diluted EPSGAAP | full-year 2026 | $6.84 to $7.04 | Raised |
| Cash flow from operations | full-year 2026 | $11.50B | Raised |
| Total revenues | 2026 Projected | $414.00B | Raised |
Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.
Press releases
Announcements Cvs Health filed with the SEC
CVS Health Announces Board Changes
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
CVS HEALTH CORPORATION REPORTS STRONG SECOND QUARTER 2026 RESULTS
Results of operations · EX-99.1 to Form 8-K
CVS HEALTH CORPORATION REPORTS STRONG FIRST QUARTER 2026 RESULTS
Results of operations · EX-99.1 to Form 8-K
CVS HEALTH CORPORATION REPORTS FOURTH QUARTER AND FULL-YEAR 2025 RESULTS
Results of operations · EX-99.1 to Form 8-K
CVS Health Updates Financial Guidance, Highlights Strength of Businesses, and Announces Strategy to Uniquely Reimagine Health Care at Investor Day Event
Regulation FD disclosure · EX-99.1 to Form 8-K
WOONSOCKET, RI (November 20, 2025) –
Other events · EX-99.1 to Form 8-K
CVS HEALTH CORPORATION REPORTS THIRD QUARTER 2025 RESULTS AND
Results of operations · EX-99.1 to Form 8-K
Initiates Voluntary Chapter 11 Process
Other events · EX-99.1 to Form 8-K
CVS HEALTH CORPORATION REPORTS SECOND QUARTER 2025 RESULTS AND
Results of operations · EX-99.1 to Form 8-K
CVS HEALTH CORPORATION REPORTS FIRST QUARTER 2025 RESULTS AND
Results of operations · EX-99.1 to Form 8-K
CVS Health Announces Chief Financial
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
CVS HEALTH CORPORATION REPORTS FOURTH QUARTER AND FULL-YEAR 2024 RESULTS
Results of operations · EX-99.1 to Form 8-K
Chief Strategy Officer & Chief Strategic
Other events · EX-99.1 to Form 8-K
Chief Strategic Advisor to the CEO
Other events · EX-99.2 to Form 8-K
Chief Strategic Advisor to the CEO
Other events · EX-99.1 to Form 8-K
Chief Strategic Advisor to the CEO
Other events · EX-99.1 to Form 8-K
Chief Strategic Advisor to the CEO
Other events · EX-99.1 to Form 8-K
CVS Health Announces Board Appointments
Material agreement · Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Prem Shah named Group President, CVS Health; Steve Nelson named President, Aetna
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
CVS HEALTH CORPORATION REPORTS THIRD QUARTER 2024 RESULTS
Results of operations · EX-99.1 to Form 8-K
CVS Health Appoints David Joyner
Results of operations · Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
CVS HEALTH CORPORATION REPORTS SECOND QUARTER 2024 RESULTS
Results of operations · EX-99.1 to Form 8-K
CVS HEALTH CORPORATION REPORTS FIRST QUARTER 2024 RESULTS AND
Results of operations · EX-99.1 to Form 8-K
CVS HEALTH REPORTS FOURTH QUARTER AND FULL-YEAR 2023 RESULTS
Results of operations · EX-99.1 to Form 8-K
CVS Health Announces Leadership Appointments
Results of operations · Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
CVS Health highlights path to accelerating long-term growth
Regulation FD disclosure · EX-99.1 to Form 8-K
CVS Health reports third quarter results
Results of operations · EX-99.1 to Form 8-K
CVS Health announces CFO Shawn
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Eighty-seven (87) percent of Aetna Medicare Advantage members in 4-star plans or higher for 2024
Regulation FD disclosure · EX-99.1 to Form 8-K
New business will bring high quality biosimilar
Regulation FD disclosure · EX-99.1 to Form 8-K
CVS Health reports second quarter results
Results of operations · EX-99.1 to Form 8-K
EX-99.1 to Form 8-K
Other events · EX-99.1 to Form 8-K
CVS HEALTH REPORTS FIRST QUARTER RESULTS,
Results of operations · EX-99.1 to Form 8-K
CVS Health completes acquisition of Oak Street
Material agreement · New financial obligation · Other events · EX-99.1 to Form 8-K
CVS HEALTH REPORTS STRONG FOURTH QUARTER AND FULL-YEAR 2022 RESULTS
Results of operations · EX-99.1 to Form 8-K
CVS Health to Acquire Oak Street Health
Regulation FD disclosure · EX-99.1 to Form 8-K
CVS Health and Oak St. Health
Regulation FD disclosure · EX-99.2 to Form 8-K
CVS Health Names David Joyner Head of Pharmacy
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
CVS HEALTH REPORTS THIRD QUARTER RESULTS
Results of operations · EX-99.1 to Form 8-K
CVS Health to Acquire Signify Health
Other events · EX-99.1 to Form 8-K